摘要 |
The invention concerns the use of a quinazoline derivative of Formula (I) wherein Q<1> includes a quinazoline ring optionally substituted with a group such as halogeno, trifluoromethyl and cyano, or a group of the formula: Q<3>-X<1>- wherein X<1> includes a direct bond and O and Q<3> includes aryl, aryl-(1-6C)alkyl, heterocyclyl and heterocyclyl-(1-6C)alkyl; each of R<2> and R<3> is hydrogen or (1-6C)alkyl; Z includes O, S and NH; and Q<2> includes aryl and aryl-(1-3C)alkyl or a pharmaceutically-acceptable salt thereof, in the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human.
|
申请人 |
ASTRAZENECA AB;ASTRAZENECA UK LIMITED;HENNEQUIN, LAURENT, FRANCOIS, ANDRE;CRAWLEY, GRAHAM, CHARLES;MCKERRECHER, DARREN;PLE, PATRICK;POYSER, JEFFREY, PHILIP;LAMBERT, CHRISTINE, MARIE, PAUL |
发明人 |
HENNEQUIN, LAURENT, FRANCOIS, ANDRE;CRAWLEY, GRAHAM, CHARLES;MCKERRECHER, DARREN;PLE, PATRICK;POYSER, JEFFREY, PHILIP;LAMBERT, CHRISTINE, MARIE, PAUL |